Pulmonary Vascular Disease News

This week, the FDA issues an EUA for tocilizumab in COVID-19; an electronic tool detects ovarian and pancreatic cancers; the delta variant accounts for 20% of new COVID-19 cases; and more.

In a preliminary analysis of the ongoing SPECTRA study, patients with pulmonary arterial hypertension treated with sotatercept had improvements in hemodynamics, exercise capacity and 6-minute walk distance.

In a large cohort of survivors of acute pulmonary embolism, disease-specific and generic health-related quality of life improved between 3 and 12 months, according to data published in Chest.

Patients with systemic sclerosis demonstrate a four-fold increased prevalence of moderate-to-severe valvular heart disease at diagnosis compared with those without systemic sclerosis, according to data published in The Journal of Rheumatology.

In the U.S., mortality trends in patients with pulmonary arterial hypertension continue to improve; however, rates remain high in those with intermediate- and high-risk characteristics, researchers reported.

Treatment with selexipag could save payers costs over 2 years compared with oral treprostinil, according to results of a comparative cost model reported at the Academy of Managed Care Pharmacy virtual meeting.

Early intervention is critical for patients who are likely to progress to serious complications from systemic sclerosis-associated interstitial lung disease, according to a presenter at the Biologic Therapies Summit.

In a post hoc analysis of the INCREASE study, patients with interstitial lung disease-associated pulmonary hypertension who continued inhaled treprostinil were less likely to experience further disease progression events vs. placebo.

Use of the DETECT algorithm was a better screening tool for systemic sclerosis-associated peripheral arterial hypertension than transthoracic echocardiogram, according to results of a new study.

For physicians, pulmonary artery hypertension poses many challenges, including the need for greater awareness and better therapies, according to an expert who spoke with Healio.